HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Neurofibromatosis 2 (Neurofibromatosis Type II)

Subscribe to New Research on Neurofibromatosis 2
Share|Follow on Twitter
An autosomal dominant disorder characterized by a high incidence of bilateral acoustic neuromas as well as schwannomas (NEURILEMMOMA) of other cranial and peripheral nerves, and other benign intracranial tumors including meningiomas, ependymomas, spinal neurofibromas, and gliomas. The disease has been linked to mutations of the NF2 gene (GENES, NEUROFIBROMATOSIS 2) on chromosome 22 (22q12) and usually presents clinically in the first or second decade of life.
Also Known As:
Neurofibromatosis Type II; Bilateral Acoustic Neurofibromatosis; Neurofibromatosis Type 2; Neurofibromatosis II; 2 Neurofibromatosis, Type; Familial Acoustic Neuroma; Type II Neurofibromatosis; Schwannoma, Acoustic, Bilateral; Acoustic Neurinoma, Bilateral; Acoustic Schwannomas, Bilateral; Familial Acoustic Neuromas; NF2 (Neurofibromatosis 2); Neurofibromatosis, Central NF2; Neurofibromatosis, Central, NF 2; Neurofibromatosis, Type 2; Neurofibromatosis, Type II; Acoustic Neurinomas, Bilateral; Acoustic Neurofibromatoses, Bilateral; Acoustic Neurofibromatosis, Bilateral; Acoustic Neuroma, Familial; Acoustic Neuromas, Familial; Acoustic Schwannoma, Bilateral; Bilateral Acoustic Neurinoma; Bilateral Acoustic Neurinomas; Bilateral Acoustic Neurofibromatoses; Bilateral Acoustic Schwannoma; Bilateral Acoustic Schwannomas; Central NF2 Neurofibromatoses; Central NF2 Neurofibromatosis; NF2s (Neurofibromatosis 2); Neurinoma, Bilateral Acoustic; Neurinomas, Bilateral Acoustic; Neurofibromatoses, Bilateral Acoustic; Neurofibromatoses, Central NF2; Neurofibromatoses, Type 2; Neurofibromatoses, Type II; Neurofibromatosis IIs; Neurofibromatosis, Bilateral Acoustic; Neuroma, Familial Acoustic; Neuromas, Familial Acoustic; Schwannoma, Bilateral Acoustic; Schwannomas, Bilateral Acoustic; Type 2 Neurofibromatoses; Type 2 Neurofibromatosis; Type II Neurofibromatoses; Neurofibromatosis, Acoustic, Bilateral; Neurofibromatosis, Central, NF2; Neuroma, Acoustic, Bilateral
Networked: 290 relevant articles (3 outcomes, 16 trials/studies) for this Disease, Comments

Relationship Network

Disease Context: Research Results

Related Diseases

1. Acoustic Neuroma (Acoustic Neurinoma)
2. Deafness (Deaf Mutism)
3. Neoplasms (Cancer)
4. Neurilemmoma (Schwannoma)
5. Meningioma (Meningiomas)

Experts

1. Gutmann, David H: 10 articles (03/2009 - 09/2002)
2. Giovannini, Marco: 9 articles (03/2009 - 08/2002)
3. Chang, Long-Sheng: 5 articles (01/2009 - 01/2002)
4. Otto, Steven R: 5 articles (12/2008 - 01/2003)
5. Brackmann, Derald E: 5 articles (12/2008 - 01/2003)
6. Scoles, Daniel R: 5 articles (01/2008 - 12/2002)
7. Sterkers, O: 5 articles (07/2007 - 01/2000)
8. Rey, A: 5 articles (07/2007 - 01/2000)
9. Bouccara, D: 5 articles (07/2007 - 01/2000)
10. Lee, Kweon-Haeng: 5 articles (12/2004 - 09/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Neurofibromatosis 2:
1. bevacizumabFDA Link
2. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
3. Neurofibromin 2 (Merlin)IBA
4. DNA (Deoxyribonucleic Acid)IBA
5. Genetic Markers (Genetic Marker)IBA
6. ParaffinIBA
7. Formaldehyde (Formol)IBA
8. SynteninsIBA
9. Secretogranin IIIBA
10. Chromogranin AIBA

Therapies and Procedures

1. Auditory Brain Stem Implants (Auditory Brainstem Implants)
2. Radiotherapy
3. Heterologous Transplantation (Xenotransplantation)
4. Cochlear Implantation
5. Auditory Brain Stem Implantation

blog comments powered by Disqus
TREATMENT OPTIONS
for Neurofibromatosis 2,
Ranking and Evidence
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.
  • Free Updates for 1 Year
  • All 3 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Evidence References
  • Sample PDF Report on Psoriasis >>
Price:$8.50 USD & Delivery via PDF download
updates for 1 year
Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:
Price:$45.00 USD access via web interface
1 year subscription
Request Bulk Institution License Details >>